NeoGenomics, Inc. (NASDAQ:NEO) headquartered in Fort Myers, will host a conference call for the investment community to discuss the 2Q20 earnings result on 28th July 2020 at 8:30 AM Eastern Time.
Those interested in listening to the conference call live via the Internet can visit www.neogenomics.com
Earnings Expectation
NeoGenomics, Inc. is reporting second quarter earnings results on Tuesday 28th July 2020, before market open. The consensus estimates from Thomson Reuters are loss of $ 0.1 per share. For the full year, analysts predict revenues of $ 426.79 million, while looking forward to loss of $ 0.04 per share.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 464.00 million ~ $ 474.00 million
Click Here For More Historical Outlooks Of NeoGenomics, Inc.
NeoGenomics, Inc., together with its subsidiaries, operates a network of cancer-focused genetic testing laboratories in the United States; and laboratories in Switzerland and Singapore. It operates in two segments, Clinical Services and Pharma Services. The companys laboratories provide genetic and molecular testing services to hospitals, pathologists, oncologists, urologists, other clinicians and researchers, pharmaceutical firms, academic centers, and other clinical laboratories.
